Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

ViroPharma

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ViroPharma's 2013 immunology sales performance.

Nabriva Therapeutics appoints chief medical officer

Nabriva Therapeutics appoints chief medical officer

Her career has seen her hold positions at Shire, ViroPharma, Pfizer, GlaxoSmithKline and Merck &Co.

Merck says drug for CMV in transplant patients hits targets

Merck says drug for CMV in transplant patients hits targets phase III testing that it acquired along with ViroPharma in 2013.

FDA grants fast track designation to Shire’s Cinryze

FDA grants fast track designation to Shire’s Cinryze At the end of 2013, Shire signed a deal with US company Viropharma for around $4.2bn which gave the company rights to Cinryze.

Pharma deals in August 2015

Pharma deals in August 2015 indication]. Interestingly, the right to make the Meritage acquisition came via the purchase of ViroPharma.

Medius Deal Watch table for February 2015

Medius Deal Watch table for February 2015 Turkey. †  US. ††  Financial details source - Viropharma's 2013 Consolidated Financial Statement.  .

1 2 3 4 5 6 7 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics